Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: A systematic review

Willemijn Steen; Rachel Blom; Olivier Busch; Michael Gerhards; Marc Besselink; Frederike Dijk; Sebastiaan Festen

doi:https://doi.org/10.1002/jso.24402

Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: A systematic review

Willemijn Steen, Rachel Blom, Olivier Busch, Michael Gerhards, Marc Besselink, Frederike Dijk, Sebastiaan Festen

Research output: Contribution to journal › Review article › Academic › peer-review

14 Citations (Scopus)

Abstract

The poor survival of patients with resectable pancreatic cancer might be related to the presence of occult peritoneal tumor cells (OPTC). This systematic review studies the prognostic value of cytology and carcinoembryonic antigen (CEA) by real-time polymerase chain reaction in peritoneal fluid. The results suggest that presence of OPTC is related to a worse survival in patients with resectable pancreatic cancer. Future studies should investigate its possible role in selecting patients for specific treatment strategies. J. Surg. Oncol. 2016;114:743-751. © 2016 Wiley Periodicals, Inc

Original language	English
Pages (from-to)	743-751
Journal	Journal of surgical oncology
Volume	114
Issue number	6
DOIs	https://doi.org/10.1002/jso.24402
Publication status	Published - 2016

Access to Document

https://doi.org/10.1002/jso.24402

Cite this

@article{f0e3ce79fc4641c2ba9ebf3a34d274f3,

title = "Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: A systematic review",

abstract = "The poor survival of patients with resectable pancreatic cancer might be related to the presence of occult peritoneal tumor cells (OPTC). This systematic review studies the prognostic value of cytology and carcinoembryonic antigen (CEA) by real-time polymerase chain reaction in peritoneal fluid. The results suggest that presence of OPTC is related to a worse survival in patients with resectable pancreatic cancer. Future studies should investigate its possible role in selecting patients for specific treatment strategies. J. Surg. Oncol. 2016;114:743-751. {\textcopyright} 2016 Wiley Periodicals, Inc",

author = "Willemijn Steen and Rachel Blom and Olivier Busch and Michael Gerhards and Marc Besselink and Frederike Dijk and Sebastiaan Festen",

year = "2016",

doi = "https://doi.org/10.1002/jso.24402",

language = "English",

volume = "114",

pages = "743--751",

journal = "Journal of surgical oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "6",

}

TY - JOUR

T1 - Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: A systematic review

AU - Steen, Willemijn

AU - Blom, Rachel

AU - Busch, Olivier

AU - Gerhards, Michael

AU - Besselink, Marc

AU - Dijk, Frederike

AU - Festen, Sebastiaan

PY - 2016

Y1 - 2016

N2 - The poor survival of patients with resectable pancreatic cancer might be related to the presence of occult peritoneal tumor cells (OPTC). This systematic review studies the prognostic value of cytology and carcinoembryonic antigen (CEA) by real-time polymerase chain reaction in peritoneal fluid. The results suggest that presence of OPTC is related to a worse survival in patients with resectable pancreatic cancer. Future studies should investigate its possible role in selecting patients for specific treatment strategies. J. Surg. Oncol. 2016;114:743-751. © 2016 Wiley Periodicals, Inc

AB - The poor survival of patients with resectable pancreatic cancer might be related to the presence of occult peritoneal tumor cells (OPTC). This systematic review studies the prognostic value of cytology and carcinoembryonic antigen (CEA) by real-time polymerase chain reaction in peritoneal fluid. The results suggest that presence of OPTC is related to a worse survival in patients with resectable pancreatic cancer. Future studies should investigate its possible role in selecting patients for specific treatment strategies. J. Surg. Oncol. 2016;114:743-751. © 2016 Wiley Periodicals, Inc

U2 - https://doi.org/10.1002/jso.24402

DO - https://doi.org/10.1002/jso.24402

M3 - Review article

C2 - 27642007

SN - 0022-4790

VL - 114

SP - 743

EP - 751

JO - Journal of surgical oncology

JF - Journal of surgical oncology

IS - 6

ER -